| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/22/2003 | US6596711 GABA B receptor agonists for use in the treatment of CNS disorders, such as muscle relaxation in spinal spasticity, cardiovascular disorders, asthma, gut motility disorders such as irritable bowel syndrome and gastroesophogeal reflux |
| 07/22/2003 | US6596710 Dosage forms of risedronate |
| 07/22/2003 | US6596709 6-sulphanoyl-3-quinolylphosphonic acid compounds |
| 07/22/2003 | US6596708 Composition for the treatment and prevention of endothelial dysfunction |
| 07/22/2003 | US6596707 Monovalent saccharides and uses thereof |
| 07/22/2003 | US6596706 For the treatment of circulatory diseases cerebral diseases |
| 07/22/2003 | US6596705 Inhibition of L-selectin and P-selection mediated binding using heparin |
| 07/22/2003 | US6596704 Spraying, painting or squirting gellan gum composition on the wound or skin injury to form an immobile gel |
| 07/22/2003 | US6596703 Promotion of wound healing utilizing steroids having reduced deteriorous systemic side effects typical of glucocorticoids, mineralocorticoids and sex steroids |
| 07/22/2003 | US6596701 S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy |
| 07/22/2003 | US6596700 Methods of treating hepatitis delta virus infection with β-L-2'-deoxy-nucleosides |
| 07/22/2003 | US6596696 Alpha-amylase inhibitor for the prophylaxis and treatment of hyperglycemia |
| 07/22/2003 | US6596695 Topical application of immixture of ascorbic acid + ascorbic acid compounds for augmenting the synthesis of epidermal ceramides |
| 07/22/2003 | US6596694 Caloporoside derivatives, methods of their preparation and use |
| 07/22/2003 | US6596691 Administering therapeutically effective amount of bactericidal/permeability-increasing protein product to a human suffering from meningococcemia |
| 07/22/2003 | US6596687 Cell adhesion inhibitors |
| 07/22/2003 | US6596530 Lactobacillus for use in the generation of food product |
| 07/22/2003 | US6596518 Culture product; lipase inhibitor |
| 07/22/2003 | US6596504 Preventing, inhibiting or enhancing binding between at least one type of pilus subunit and at least one type of periplasmic molecular chaperone in the pilus-forming bacteria for therapy or prophylaxis of diseases |
| 07/22/2003 | US6596497 Screening of antiviral compounds targeted to the HIV-1 gp41 core structure |
| 07/22/2003 | US6596491 Tenascin-C nucleic acid ligands |
| 07/22/2003 | US6596477 Treatment and prevention of immunodeficiency virus infection by administration of non-pyrogenic derivatives of lipid A |
| 07/22/2003 | US6596473 Detection of antiapotosis protein; obtain genetically engineered cells, measure viable cells, incubate with antiapoptosis agent, compare with control, evaluate adjustment in apoptosis activity |
| 07/22/2003 | US6596321 Pharmaceutical composition for treating angiocardiopathy and the method of producing thereof |
| 07/22/2003 | US6596317 Fenofibrate pharmaceutical composition having high bioavailability and method for preparing it |
| 07/22/2003 | US6596315 Minimizing degradation; dissolveing acid labile substance in hydrate form and applying a fluid gas |
| 07/22/2003 | US6596309 Together with lipophilic silicone oil carriers in the form of a soft gelatin capsule |
| 07/22/2003 | US6596307 Crystalline cefaclor with reduced water content |
| 07/22/2003 | US6596302 Infant formulas containing long-chain polyunsaturated fatty acids and uses thereof |
| 07/22/2003 | US6596298 Pullulan and antimicrobially effective amounts of thymol, methyl salicylate, eucalyptol and menthol |
| 07/22/2003 | US6596296 Three dimensional matrices for growing cells; controlled delivery of therapeutic agents |
| 07/22/2003 | US6596295 Aqueous solution for treating degenerative or autoimmune diseases and/or as an immunomodulatory agent |
| 07/22/2003 | US6596289 Knitted garment of cotton, nylon or polyester adapted for tight fitting; contains polyimine which partially decomposes from exposure to skin pH, moisture and/or heat releasing ascorbic acid, lipoic acid and/or isoflavones |
| 07/22/2003 | US6596284 Treating eczema with a combination of isotonic saline ocean® and nasal mast cell stabilizers |
| 07/22/2003 | US6596268 Viruses for the treatment of cellular proliferative disorders |
| 07/22/2003 | US6596267 Such as ethylene glycol-phenylboronic acid copolymer; prosthetics and implant coatings; readily adsorbs onto body tissues in situ providing steric barrier minimizing post-operative adhesion |
| 07/22/2003 | US6596266 Compositions containing minoxidil and saw palmetto for treating baldness |
| 07/22/2003 | US6596265 Use of sophorolipids comprising diacetyl lactones as agent for stimulating skin fibroblast metabolism |
| 07/22/2003 | US6596262 Modulated release particles for aerosol delivery |
| 07/22/2003 | US6596261 Maximizing drug delivery to lungs |
| 07/22/2003 | US6596206 Generation of pharmaceutical agent particles using focused acoustic energy |
| 07/22/2003 | US6595926 Method for evaluating and treating hypertension |
| 07/22/2003 | CA2353693C Pharmaceutical composition containing citalopram |
| 07/22/2003 | CA2294422C Tartrate salt of a substituted dipeptide |
| 07/22/2003 | CA2294178C Process for the selective preparation of z-isomers of 3-(2-substituted vinyl)cephalosporins |
| 07/22/2003 | CA2276203C N-(pyridinylamino)isoindolines and related compounds |
| 07/22/2003 | CA2275602C Novel carboxy substituted cyclic carboxamide derivatives |
| 07/22/2003 | CA2275166C Novel benzopyran derivatives |
| 07/22/2003 | CA2269923C Pharmaceutical compositions containing plasma protein |
| 07/22/2003 | CA2245250C Benzofuran-acrylic acid derivatives and their use as modulators of rxrs or rars receptors |
| 07/22/2003 | CA2243274C Male contraceptive implant |
| 07/22/2003 | CA2239603C Quinolines and quinazolines useful in therapy |
| 07/22/2003 | CA2228572C Nk-1 receptor antagonists for prevention of neurogenic inflammation in gene therapy |
| 07/22/2003 | CA2198833C Carnitine derivative-containing medicament for treating chronic arteriosclerosis obliterans |
| 07/22/2003 | CA2195185C Ascorbyl-phosphoryl-cholesterol |
| 07/22/2003 | CA2109320C Peptide nucleic acids |
| 07/22/2003 | CA2045891C Oligonucleotide analogs with terminal 3'-3' or 5'-5' internucleotide linkages |
| 07/21/2003 | CA2416791A1 A receptor-ligand pairing for immune response |
| 07/21/2003 | CA2368656A1 Receptor-ligand pairing for anti-inflammatory response |
| 07/17/2003 | WO2003057926A1 Gene products differentially expressed in cancerous breast cells and their methods of use |
| 07/17/2003 | WO2003057911A2 Single nucleotide polymorphisms predicting cardiovascular disease and medication efficacy |
| 07/17/2003 | WO2003057898A2 Methods and materials for modulating p2x2 |
| 07/17/2003 | WO2003057893A1 Process for the preparation of immunomodulatory polysaccharides from aloe |
| 07/17/2003 | WO2003057874A1 Disease markers for renal diseaes and utilization thereof |
| 07/17/2003 | WO2003057835A2 Pak5-related compositions and methods |
| 07/17/2003 | WO2003057830A2 Compositions and methods for hydroxylating epothilones |
| 07/17/2003 | WO2003057822A2 Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends |
| 07/17/2003 | WO2003057730A1 Ligand for g-protein coupled receptor gpr43 and uses thereof |
| 07/17/2003 | WO2003057726A1 Cytotoxic cyplasin of the sea hare, Aplysia punctata, cDNA cloning and expression of bioreactive recombinants |
| 07/17/2003 | WO2003057721A2 Substituted amino carboxamides for the treatment of alzheimer's disease |
| 07/17/2003 | WO2003057707A1 2-o-( -d-glucopyranosyl)ascorbic acid, process for its production, and foods and cosmetics containing compositions comprising it |
| 07/17/2003 | WO2003057700A1 Compositions containing pigmentatin inhibitor, use thereof and process for producing the same |
| 07/17/2003 | WO2003057699A1 Dibenzodiazepine derivates, their preparation and use |
| 07/17/2003 | WO2003057698A2 Spiroazacyclic compounds as monoamine receptor modulators |
| 07/17/2003 | WO2003057697A1 Derivatives of 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, the preparation thereof and the application of same in therapeutics |
| 07/17/2003 | WO2003057696A1 Deazapurines and uses thereof |
| 07/17/2003 | WO2003057694A1 Method for producing scopine esters |
| 07/17/2003 | WO2003057693A1 5-membered cyclic compounds |
| 07/17/2003 | WO2003057692A1 Novel crystalline forms of meloxicam and the preparation and interconversion methods thereof |
| 07/17/2003 | WO2003057691A1 Process and intermediates for pyridazinone antidiabetic agents |
| 07/17/2003 | WO2003057690A1 Indolinone derivatives useful as protein kinase inhibitors |
| 07/17/2003 | WO2003057688A2 Oxo or oxy-pyridine compounds as 5-ht4 receptor modulators |
| 07/17/2003 | WO2003057685A1 Luminacin analogs and uses thereof |
| 07/17/2003 | WO2003057684A1 Process for the preparation of simvastatin |
| 07/17/2003 | WO2003057676A1 3,4-di-substituted pyridazinediones as cxc chemokine receptor antagonists |
| 07/17/2003 | WO2003057674A1 4-sulfide / sulfoxide / sulfonyl-1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor |
| 07/17/2003 | WO2003057673A1 1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor |
| 07/17/2003 | WO2003057672A2 Tetrahydroquinoline analogues as muscarinic agonists |
| 07/17/2003 | WO2003057670A2 Indoles as naaladase inhibitors |
| 07/17/2003 | WO2003057669A1 Androgen receptor antagonists |
| 07/17/2003 | WO2003057666A2 Inhibitors of dipeptidyl peptidase iv |
| 07/17/2003 | WO2003057664A1 Carboxamidine derivatives and their use in the treatment of vascular diseases |
| 07/17/2003 | WO2003057661A1 Prodrugs of excitatory amino acids |
| 07/17/2003 | WO2003057650A2 Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoate |
| 07/17/2003 | WO2003057278A2 Drug delivery system for sustained delivery of glipizide |
| 07/17/2003 | WO2003057265A1 Adhesive bandage containing an antimicrobial and an hemostatic agent |
| 07/17/2003 | WO2003057255A1 Drugs against obeisty and drugs against fatty liver |
| 07/17/2003 | WO2003057254A1 Preventives/remedies for urinary disturbance |
| 07/17/2003 | WO2003057252A1 Human mast cell-expressed membrane proteins |
| 07/17/2003 | WO2003057250A1 Cancer treatment |